Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Oliver Jonas
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Keros Therapeutics
Payment for services (e.g., consulting fees, honoraria, paid authorship)
The research will assess the use of implantable microdevices (IMD) to measure local intratumor response to multiple agents with the long-term goal of developing a treatment regimen for men with high-risk prostate cancer to treat occult metastatic disease as well as the local tumor by utilizing neoadjuvant therapy. Kibur Medical is developing IMDs. While the company is primarily focused on breast cancers, the use of a similar device in prostate cancer, if successful, it could increase interest in Kibur’s devices.
Pilot study of an implantable microdevice to test multiple drug responses in prostate cancer patients
This project will demonstrate that micro-doses of multiple agents can be used to effectively screen for and allow the specific tailoring of an optimal treatment with a neo-adjuvant regimen, for patients with high-risk prostate cancer. In addition, the research will be of significance, because we will be able to correlate potential biomarkers of tumor response to multiple drugs by examining the tumor for genetic and physiologic changes resulting from the micro-doses, thus contributing to a broader impact on onco-biology.
Filed on April 17, 2019.
Tell us what you know about Oliver Jonas's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.